Robert Lupinacci
Impact in
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 19
- Pneumonia and Respiratory Infections 14
- Fungal Infections and Studies 5
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Respiratory viral infections research 2
-
- Antifungal resistance and susceptibility 13
- Co-authors
- Carole A. Sable (10 shared papers)Nicholas A. Kartsonis (9 shared papers)Arnaldo Lopes Colombo (3 shared papers)John R. Perfect (2 shared papers)Robert F. Betts (2 shared papers)Luis Thompson-Moya (1 shared paper)Coleman Rotstein (1 shared paper)Michael Bourque (5 shared papers)
- Journals
- Vaccine (5 papers)Open Forum Infectious Diseases (2 papers)New England Journal of Medicine (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Medical Mycology (1 paper)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
Robert Lupinacci
34 papers receiving 2.5k citations
Robert Lupinacci's Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 2.0k
- Applied Microbiology and Biotechnology 94
- Epidemiology 1.6k
- Small Animals 202
- Oncology 325
Countries citing papers authored by Robert Lupinacci
This map shows the geographic impact of Robert Lupinacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lupinacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lupinacci more than expected).
Fields of papers citing papers by Robert Lupinacci
This network shows the impact of papers produced by Robert Lupinacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lupinacci. The network helps show where Robert Lupinacci may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lupinacci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis Hit paper breakdown → | 2002 | 1100 |
| 2 | Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia Hit paper breakdown → | 2004 | 724 |
| 3 | 2002 | 242 | |
| 4 | 2003 | 109 | |
| 5 | 2005 | 66 | |
| 6 | 2012 | 39 | |
| 7 | 2010 | 37 | |
| 8 | 2007 | 37 | |
| 9 | 2017 | 34 | |
| 10 | 2002 | 32 | |
| 11 | 2007 | 29 | |
| 12 | 2006 | 28 | |
| 13 | 2023 | 28 | |
| 14 | 2011 | 23 | |
| 15 | 2023 | 15 | |
| 16 | 2023 | 15 | |
| 17 | 2011 | 13 | |
| 18 | 2023 | 13 | |
| 19 | 2024 | 11 | |
| 20 | 2022 | 11 |
About Robert Lupinacci
Robert Lupinacci is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (14 papers), Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (5 papers), Phosphodiesterase function and regulation (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Respiratory viral infections research (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Applied Microbiology and Biotechnology (94 citations), Epidemiology (1.6k citations), Small Animals (202 citations) and Oncology (325 citations). Robert Lupinacci has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Carole A. Sable, Nicholas A. Kartsonis, Arnaldo Lopes Colombo, John R. Perfect, Robert F. Betts, Luis Thompson-Moya, Coleman Rotstein, Michael Bourque, Hedy Teppler and Johan Maertens. Their work appears in journals such as Vaccine, Open Forum Infectious Diseases, New England Journal of Medicine, European Journal of Clinical Microbiology & Infectious Diseases and Medical Mycology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.